Addressing Health Disparities in Clinical Trials

Addressing Health Disparities in Clinical Trials

Presented by AstraZeneca and the American Cancer Society Cancer Action Network

Tuesday, November 10th
9 AM to 10 AM
A Virtual Event

Register Today
fightcancer.org/2020MAFallForum

Clinical trials are a key part of cancer research, enabling the development of better drugs and treatments for cancer. Finding the right set of patients to conduct comprehensive and effective clinical trials in oncology is critical to giving all patients an equal opportunity to live a healthy life.  Unfortunately, there are many barriers to achieving diverse clinical trial participation which have only been compounded by Covid-19.  This expert panel will identify those barriers along with potential solutions to achieve meaningful and scientific diversity in clinical trials.

Moderator:

Alice Pomponio
Advisor, Red Sky Partners LLC
Faculty, MIT HST Sloan
Founder and Managing Director, Accendo

Panelists:

Dr. Christopher Lathan
Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Director, Cancer Care Equity Program
Assistant Professor of Medicine, Harvard Medical School

Dr. Pandy Opima
Clinical Trial Diversity Lead, CMO Office, AstraZeneca

Mark Fleury, PhD
Principal, Policy Development – Emerging Science, American Cancer Society Cancer Action Network